Clinical trial
Neuroendocrine Brake for Type 2 Diabetes Mellitus
NCT00450710 · Medtronic - MITG, Industry · Completed
Key facts
| NCT number | NCT00450710 |
|---|---|
| Title | Neuroendocrine Brake for Type 2 Diabetes Mellitus |
| Official title | Phase IV Study of Neuroendocrine Brake Surgical Procedure for Type 2 Diabetes Mellitus |
| Lead sponsor | Medtronic - MITG, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Diabetes |
| Intervention type | Procedure |
| Interventions | ileal interposition with a sleeve gastrectomy |
| Enrollment | 40 |
| Start date | Mar 1, 2006 |
| Primary completion | Sep 1, 2008 |
| Completion | Sep 1, 2009 |
| First posted | Mar 22, 2007 |
| Last update posted | Aug 22, 2014 |
| Countries | Brazil |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: